User profiles for "author:Cooke Graham"

Graham Cooke

Imperial College
Verified email at imperial.ac.uk
Cited by 46614

Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing

TM Rawson, LSP Moore, N Zhu… - Clinical infectious …, 2020 - academic.oup.com
Background To explore and describe the current literature surrounding bacterial/fungal
coinfection in patients with coronavirus infection. Methods MEDLINE, EMBASE, and Web of …

Genetics of susceptibitlity to human infectious disease

GS Cooke, AVS Hill - Nature Reviews Genetics, 2001 - nature.com
Abstract Before Robert Koch's work in the late nineteenth century, diseases such as
tuberculosis and leprosy were widely believed to be inherited disorders. Heritability of …

Technologies for global health

P Howitt, A Darzi, GZ Yang, H Ashrafian, R Atun… - The Lancet, 2012 - thelancet.com
Executive summary Availability of health technology is inversely related to health need.
Although health-care systems in high-income countries make extensive use of technology …

[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses

W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa… - Cell, 2022 - cell.com
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B. 1.1.
529 was announced, containing far more mutations in Spike (S) than previously reported …

The global burden of cancer 2013

C Fitzmaurice, D Dicker, A Pain, H Hamavid… - JAMA …, 2015 - jamanetwork.com
Importance Cancer is among the leading causes of death worldwide. Current estimates of
cancer burden in individual countries and regions are necessary to inform local cancer …

[HTML][HTML] Global distribution and prevalence of hepatitis C virus genotypes

JP Messina, I Humphreys, A Flaxman, A Brown… - Hepatology, 2014 - journals.lww.com
Hepatitis C virus (HCV) exhibits high genetic diversity, characterized by regional variations
in genotype prevalence. This poses a challenge to the improved development of vaccines …

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013 …

CJL Murray, RM Barber, KJ Foreman, AA Ozgoren… - The Lancet, 2015 - thelancet.com
Summary Background The Global Burden of Disease Study 2013 (GBD 2013) aims to bring
together all available epidemiological data using a coherent measurement framework …

The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

JD Stanaway, AD Flaxman, M Naghavi, C Fitzmaurice… - The Lancet, 2016 - thelancet.com
Background With recent improvements in vaccines and treatments against viral hepatitis, an
improved understanding of the burden of viral hepatitis is needed to inform global …

[HTML][HTML] Persistent COVID-19 symptoms in a community study of 606,434 people in England

M Whitaker, J Elliott, M Chadeau-Hyam, S Riley… - Nature …, 2022 - nature.com
Long COVID remains a broadly defined syndrome, with estimates of prevalence and
duration varying widely. We use data from rounds 3–5 of the REACT-2 study (n= 508,707; …

[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …

CD Russell, CJ Fairfield, TM Drake, L Turtle… - The Lancet …, 2021 - thelancet.com
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …